AU2003210741A1 - Ptpase inhibitors and methods of using the same - Google Patents

Ptpase inhibitors and methods of using the same

Info

Publication number
AU2003210741A1
AU2003210741A1 AU2003210741A AU2003210741A AU2003210741A1 AU 2003210741 A1 AU2003210741 A1 AU 2003210741A1 AU 2003210741 A AU2003210741 A AU 2003210741A AU 2003210741 A AU2003210741 A AU 2003210741A AU 2003210741 A1 AU2003210741 A1 AU 2003210741A1
Authority
AU
Australia
Prior art keywords
methods
same
ptpase inhibitors
ptpase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210741A
Inventor
Taolin Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/238,007 external-priority patent/US7416723B2/en
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Publication of AU2003210741A1 publication Critical patent/AU2003210741A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2003210741A 2002-01-30 2003-01-30 Ptpase inhibitors and methods of using the same Abandoned AU2003210741A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35301902P 2002-01-30 2002-01-30
US60/353,019 2002-01-30
US10/238,007 US7416723B2 (en) 2001-09-07 2002-09-09 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
US10/238,007 2002-09-09
PCT/US2003/002770 WO2003063788A2 (en) 2002-01-30 2003-01-30 PTPase INHIBITORS AND METHODS OF USING THE SAME

Publications (1)

Publication Number Publication Date
AU2003210741A1 true AU2003210741A1 (en) 2003-09-02

Family

ID=27668411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210741A Abandoned AU2003210741A1 (en) 2002-01-30 2003-01-30 Ptpase inhibitors and methods of using the same

Country Status (2)

Country Link
AU (1) AU2003210741A1 (en)
WO (1) WO2003063788A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215629A1 (en) * 2001-09-07 2005-09-29 Taolin Yi PTPase inhibitors and methods of using the same
US20070026398A1 (en) * 2003-03-03 2007-02-01 Farnsworth Amanda L Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer
WO2006000069A1 (en) * 2004-06-24 2006-01-05 Universidade Federal De Minas Gerais - Ufmg Pharmaceutical compositions consisting of cyclodextrin and an antimony derivative, their preparation as well as their use
NL1026931C2 (en) * 2004-08-31 2006-03-01 Friesland Brands Bv ACE-inhibiting whey hydrolysates.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798339A (en) * 1990-12-17 1998-08-25 University Of Manitoba Treatment method for cancer
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith

Also Published As

Publication number Publication date
WO2003063788A3 (en) 2004-03-18
WO2003063788A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003215121A1 (en) Dvd and method of using same
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003297681A1 (en) Abrasive webs and methods of making the same
AU2003220586A1 (en) Game piece and system and method of use
AU2003277597A1 (en) Cleaning composition and method of cleaning therewith
AU2003220558A1 (en) Amide compounds and methods of using the same
ZA200601293B (en) Proteasome inhibitors and methods of using the same
AU2003259717A1 (en) Modulators of rabggt and methods of use thereof
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2003299815A1 (en) Matriptase inhibitors and methods of use
AU2003210874A1 (en) Cleaning device and method of construction
AU2003256647A1 (en) Stencil and method of using the same
AU2003215244A1 (en) Complexes and methods of using same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase